{"gene":"RASGRF1","run_date":"2026-06-10T06:43:36","timeline":{"discoveries":[{"year":2003,"finding":"RasGRF1 directly interacts with the NR2B subunit (but not NR2A or NR1) of NMDA receptors in vivo and in vitro; specific disruption of this interaction in living neurons abrogates NMDAR-dependent ERK activation, establishing RasGRF1 as the Ca2+/calmodulin-dependent regulator linking NR2B-containing NMDARs to the ERK kinase pathway.","method":"Co-immunoprecipitation (in vivo and in vitro), disruption peptides in living neurons, ERK activation assays","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP in vivo and in vitro, functional disruption in live neurons, replicated across multiple experimental contexts","pmids":["14622581"],"is_preprint":false},{"year":2006,"finding":"Ras-GRF1 mediates signaling from NR2B-containing NMDARs to the Rac effector p38 MAP kinase to promote long-term depression (LTD) in the CA1 hippocampus of postpubescent mice, while Ras-GRF2 (not Ras-GRF1) mediates signaling from NR2A-containing NMDARs to ERK1/2 to promote LTP.","method":"Genetic knockout mice (Ras-GRF1 KO, Ras-GRF2 KO), electrophysiology (LTP/LTD), pharmacological receptor subtype blockade (ifenprodil, NVP-AAM077)","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean KO with defined synaptic plasticity phenotype, pharmacological dissection of NMDAR subtypes, multiple orthogonal methods","pmids":["16467520"],"is_preprint":false},{"year":2002,"finding":"The N-terminal region of Ras-GRF1 (containing PH domain, coiled-coil, and adjacent sequences) binds to the scaffold protein IB2/JIP2, which scaffolds the p38 MAP kinase cascade (MLK3-MKK3-p38); Ras-GRF1 binding to IB2/JIP2 selectively potentiates p38 activation but not JNK activation and increases assembly of the p38 signaling cassette.","method":"Co-immunoprecipitation, overexpression in cells, kinase activation assays","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP with functional readout, single lab, two orthogonal methods (binding + signaling assay)","pmids":["12024021"],"is_preprint":false},{"year":2014,"finding":"CARD9 mediates Dectin-1-induced ERK activation by linking Ras-GRF1 to H-Ras: Dectin-1 engagement initiates Syk-dependent phosphorylation of Ras-GRF1, and phosphorylated Ras-GRF1 recruits and activates H-Ras through forming a complex with CARD9, leading to downstream ERK activation and antifungal cytokine production.","method":"Co-immunoprecipitation, phosphorylation assays, CARD9 KO cells, ERK activation assays, in vivo infection model","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — Co-IP showing complex formation, KO functional phenotype, in vivo validation, multiple orthogonal methods","pmids":["25267792"],"is_preprint":false},{"year":1999,"finding":"Phosphorylation of Ras-GRF1 at Ser916 is a major in vivo phosphorylation site required for full activation of its guanine nucleotide exchange activity by muscarinic receptors; Ser916 is a substrate for protein kinase A both in vivo and in vitro, establishing a link between the cAMP and Ras signaling systems, though PKA phosphorylation alone is not sufficient to activate RasGRF1.","method":"Site-directed mutagenesis, in vivo phosphorylation mapping, in vitro kinase assay, GEF activity assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — site-directed mutagenesis with in vitro kinase assay and in vivo phosphorylation, functional GEF activity readout","pmids":["10601308"],"is_preprint":false},{"year":2003,"finding":"Phosphorylation of Ras-GRF1 at Ser916/898 is required for maximal Ras-dependent neurite outgrowth in PC12 cells and is increased by protein kinase A activation in brain slices; a phospho-specific antibody confirmed regulated phosphorylation of endogenous Ras-GRF1 in rat forebrain, including in the dendritic tree of prefrontal cortex neurons.","method":"Phospho-specific antibody, confocal immunofluorescence, 32P incorporation in brain slices, mutagenesis, neurite outgrowth assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — mutagenesis with functional assay, phospho-specific antibody validation in endogenous tissue, multiple orthogonal methods","pmids":["12538592"],"is_preprint":false},{"year":2006,"finding":"Ras-GRF1 has separate GEF activities for H-Ras (through its Cdc25 domain) and Rac1 (through its DH domain); coordinated activation of both is required for full morphological effects in neurons. The Rac GEF-containing truncation (GRFdeltaC) binds H-Ras·GTP directly, coupling H-Ras activation to Rac-dependent cell expansion via PI3K/Akt.","method":"Truncation mutant expression, pulldown assays from bacterial lysates, co-immunoprecipitation from HEK293 cells, dominant-negative Rac1/RhoA, pharmacological inhibitors (wortmannin), morphological analysis","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 1 / Strong — domain dissection with mutagenesis, in vitro pulldown and Co-IP, functional morphological readout with multiple inhibitors","pmids":["16481401"],"is_preprint":false},{"year":2007,"finding":"Filamin A (FLNa) down-regulates Ras-GRF1 protein stability through destabilization and ubiquitylation of Ras-GRF1, thereby suppressing constitutive H-Ras/MAPK-ERK activation and reducing MMP-9 transcription in melanoma cells; ectopic Ras-GRF1 restores ERK activation and MMP-9 elevation, while a catalytically inactive dominant-negative Ras-GRF1 reduces MMP-9 expression.","method":"Ubiquitylation assay, MMP-9 promoter-luciferase reporter, dominant-negative Ras-GRF1, ectopic expression, in vitro kinase assay","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — dominant-negative and overexpression with functional readout, ubiquitylation assay, single lab","pmids":["17389601"],"is_preprint":false},{"year":2003,"finding":"Ras-GRF1 is expressed in pancreatic islets; GRF1-deficient mice exhibit impaired beta-cell proliferation and reduced neogenesis, and isolated islets from GRF1 knockouts fail to activate Akt and Erk downstream of IGF-I treatment, demonstrating that Ras-GRF1 is required for IGF-I signaling in beta cells.","method":"Knockout mice, isolated islet IGF-I stimulation, immunoblot for Akt/Erk activation, glucose tolerance tests, histology","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean KO with defined cellular signaling phenotype, multiple orthogonal measurements (signaling, proliferation, metabolic function)","pmids":["12805218"],"is_preprint":false},{"year":1993,"finding":"Human H-GRF55/RASGRF1 encodes a Ras-specific guanine nucleotide-releasing factor that functions in vitro to promote GDP release from Ras; expression in yeast reverses cdc25.5 and RAS2 Ala-22 mutations, and in CHO cells transactivates a Ras-responsive reporter element.","method":"In vitro GEF assay with recombinant GST-fusion protein, yeast complementation, mammalian cell reporter assay","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct in vitro GEF assay, yeast genetic complementation, mammalian functional assay — multiple independent systems","pmids":["7684828"],"is_preprint":false},{"year":2005,"finding":"The differentially methylated domain (DMD) at the Rasgrf1 locus functions as an enhancer blocker that binds CTCF in a methylation-sensitive manner; CTCF binds the unmethylated maternal allele to silence expression, while repeat-mediated methylation on the paternal allele prevents CTCF binding and allows expression.","method":"CTCF binding assays, in vitro enhancer-blocking assay, in vivo imprinting analysis with extra-enhancer transgene, methylation analysis","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct CTCF binding assay, in vitro and in vivo enhancer-blocking, multiple experimental systems","pmids":["16314537"],"is_preprint":false},{"year":2001,"finding":"A direct repeat sequence immediately 3' of the differentially methylated domain (DMD) at Rasgrf1 is required for establishing paternal allele-specific DNA methylation in the male germ line; loss of the repeat abolishes DMD methylation and imprinted expression, establishing the repeat-DMD binary switch as the imprinting control region.","method":"Targeted deletion of repeat sequence in mice, bisulfite methylation analysis, allele-specific expression analysis","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct in vivo genetic deletion with methylation and expression phenotype, multiple analyses","pmids":["11753386"],"is_preprint":false},{"year":2011,"finding":"piRNA pathway components are required for de novo methylation of the Rasgrf1 DMD in the paternal germ line; piRNAs generated from a separate locus target a retrotransposon sequence within a noncoding RNA spanning the DMD, and the direct repeat acts as a promoter for this RNA, directing sequence-specific methylation.","method":"piRNA pathway mutant mice (Mili, Miwi2 knockouts), bisulfite sequencing, RNA analysis","journal":"Science","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO of piRNA pathway components with direct methylation phenotype at endogenous locus, multiple pathway mutants","pmids":["21566194"],"is_preprint":false},{"year":2009,"finding":"Ras-GRF1 is required for ERK1/2 activation by glutamate or dopamine D1 receptor agonists in striatal medium spiny neurons of the direct pathway; Ras-GRF1 integrates glutamate and dopamine signals to activate ERK and drive long-term behavioral responses to cocaine including locomotor sensitization and conditioned place preference.","method":"Ras-GRF1 KO and overexpressing transgenic mice, striatal primary cultures, organotypic slices, immunoblot/immunofluorescence for pERK, behavioral assays","journal":"Biological psychiatry","confidence":"High","confidence_rationale":"Tier 2 / Strong — KO and gain-of-function with defined signaling and behavioral phenotypes, multiple orthogonal methods","pmids":["19446794"],"is_preprint":false},{"year":2010,"finding":"Dominant-negative forms of Ras-GRF1 delivered by lentiviral vectors into the striatum cause dramatic reversion of L-DOPA-induced dyskinesia in a non-human primate model, demonstrating that Ras-GRF1-dependent Ras-ERK signaling in the striatum is mechanistically required for dyskinesia expression.","method":"Ras-GRF1 KO mice, lentiviral dominant-negative Ras-GRF1 in primate model, behavioral scoring (AIMs scale)","journal":"PNAS","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO and dominant-negative intervention with quantitative behavioral phenotype, replicated across rodent and primate models","pmids":["21115823"],"is_preprint":false},{"year":2006,"finding":"The microtubule-destabilizing factor SCLIP binds the Dbl-homology (DH) domain of RasGRF1 (identified by yeast two-hybrid) and selectively inhibits RasGRF1-mediated activation of the Rac/p38 MAPK pathway without affecting the Ras/ERK pathway; SCLIP co-expression counteracts RasGRF1-induced neurite outgrowth in PC12 cells.","method":"Yeast two-hybrid, co-immunoprecipitation, Rac/p38 and Ras/ERK activity assays, neurite outgrowth assay","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — yeast two-hybrid with Co-IP confirmation, functional pathway dissection, single lab","pmids":["17135267"],"is_preprint":false},{"year":2005,"finding":"Gs-coupled serotonin 5-HT7 receptor stimulation induces protein kinase A-dependent phosphorylation of endogenous human Ras-GRF1 at Ser927 (equivalent to mouse Ser916), and deletion of the Ca2+/calmodulin-binding IQ domain (residues 1-225) reduces both basal and serotonin-stimulated ERK1/2 phosphorylation, indicating the IQ domain is required for full Ras-GRF1 activity downstream of Gs-coupled receptors.","method":"Phosphorylation assay, deletion mutant expression, ERK1/2 phosphorylation immunoblot, intracellular Ca2+ measurement","journal":"The FEBS journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — deletion mutant with functional signaling readout, endogenous phosphorylation confirmed, single lab","pmids":["15853814"],"is_preprint":false},{"year":1999,"finding":"RasGRF1 directly interacts with the intracellular domain of the activated TrkA receptor tyrosine kinase in a kinase-activity-dependent manner (yeast two-hybrid and in vitro), and RasGRF1 is directly phosphorylated by TrkA; the interaction is highly specific for TrkA over TrkB and TrkC and is independent of the major TrkA phosphotyrosine sites Tyr499 and Tyr794.","method":"Yeast two-hybrid, in vitro kinase assay, specificity comparisons with TrkB/TrkC","journal":"Journal of molecular neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — yeast two-hybrid with in vitro kinase confirmation, multiple Trk specificity comparisons, single lab","pmids":["10691301"],"is_preprint":false},{"year":2012,"finding":"The transcription factor Zac1/Plagl1 directly represses Rasgrf1 expression in pancreatic beta cells; doubling Zac1 expression reduces Rasgrf1 levels, impairs stimulus-induced MAPK and PI3K pathway activation, and reduces insulin secretion, and normalizing Rasgrf1 expression reverses this phenotype.","method":"Transfection/overexpression in beta cells, rescue by Rasgrf1 normalization, MAPK/PI3K pathway assays, insulin secretion assay, diabetic mouse transplantation model","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — causal rescue experiment with signaling readout, multiple functional assays, single lab","pmids":["22547676"],"is_preprint":false},{"year":2010,"finding":"Disruption of the NR2B-RasGRF1 interaction dramatically impairs dendritic branch formation in ventral spinal cord neurons and hippocampal neurons, establishing that the NR2B-RasGRF1 association is required for NR2B-driven dendritogenesis.","method":"NR2B interaction-disrupting mutants, NR2-null neurons with exogenous NR2A or NR2B introduction, dendritic morphology analysis, electrophysiology","journal":"Journal of neurophysiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — specific interaction disruption mutants with defined morphological and electrophysiological phenotypes, single lab","pmids":["20107120"],"is_preprint":false},{"year":2015,"finding":"CARD9 p.Y91H mutation specifically impairs the ability of CARD9 to complex with RASGRF1 (while BCL10/MALT1 association is intact), leading to impaired activation of ERK and NF-κB in monocytes and a defective GM-CSF response, establishing the CARD9/RASGRF1/ERK/GM-CSF axis as critical for antifungal immunity.","method":"Immunoprecipitation (CARD9-RASGRF1 complex), signaling assays (pERK, NF-κB) in patient-derived cells, CARD9 mutant analysis","journal":"The Journal of allergy and clinical immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP with hypomorphic mutant and functional signaling/cytokine readout in primary patient cells, single lab","pmids":["26521038"],"is_preprint":false},{"year":2012,"finding":"RasGRF1 is required for activation of the Ras/ERK and AKT pathways downstream of pro-metastatic factors (SDF-1, HGF/SF, IGF-2, insulin) in alveolar rhabdomyosarcoma cells; shRNA knockdown of RasGRF1 abolishes ligand-induced MAPK/AKT phosphorylation and eliminates chemotactic responses, and RasGRF1-depleted cells form significantly smaller tumors in vivo.","method":"shRNA knockdown, MAPK/AKT phosphorylation assays, chemotaxis assay, xenograft tumor model","journal":"International journal of oncology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — RNAi with defined signaling and in vivo phenotype, single lab","pmids":["22752028"],"is_preprint":false},{"year":2019,"finding":"The NR2B-NMDAR/RasGRF1/NOX2 pathway promotes superoxide production required for dendritogenesis; disrupting the NR2B-RasGRF1 interaction reduces superoxide levels (measured with DHE) and inhibits dendritic branching in hippocampal neurons, placing RasGRF1 as a required intermediary between NR2B-NMDARs and NOX2-dependent reactive oxygen species generation.","method":"Dihydroethidium (DHE) fluorescence for superoxide detection, NR2B-RasGRF1 interaction-disrupting peptide, dendritic branching analysis in primary hippocampal neurons","journal":"Journal of cellular physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — specific interaction disruption with functional superoxide and morphological readouts, single lab","pmids":["31245854"],"is_preprint":false},{"year":2014,"finding":"GRF1 is expressed in newly born hippocampal neurons and promotes late stages of adult neurogenesis (dendritic arborization and survival of 2-3 week-old new neurons) in an age-dependent manner; retroviral shRNA knockdown specifically in new neurons phenocopies the reduced neurogenesis of global GRF1 knockout.","method":"Knockout mice, BrdU labeling, retroviral shRNA in new neurons, dendritic morphology analysis","journal":"Hippocampus","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — cell-autonomous KD with retrovirus phenocopies global KO, multiple measures of neurogenesis","pmids":["24174283"],"is_preprint":false},{"year":2018,"finding":"BDNF induces R-Ras activation through RasGRF1 acting as a GEF for R-Ras; RNAi knockdown and overexpression experiments show RasGRF1 is required for BDNF-induced R-Ras activation and axonal growth, and PKA-dependent phosphorylation of RasGRF1 at Ser916/898 is required for full GEF activity in this pathway.","method":"RNA interference, overexpression, R-Ras activation assay (pulldown), axonal morphology analysis, phosphorylation assay","journal":"Biochemistry and biophysics reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — RNAi and overexpression with R-Ras activity pulldown and functional axonal growth readout, single lab","pmids":["30582008"],"is_preprint":false},{"year":2018,"finding":"TrkB activation by BDNF uncouples RasGRF1 from NR2B and recruits it to TrkB; NMDA stimulation recruits RasGRF1 to NR2B, but co-stimulation with BDNF shifts RasGRF1 association to TrkB, and TrkB stimulates tyrosine phosphorylation of RasGRF1, promoting ERK activation and neurite outgrowth while reducing NR2B-LTD signaling.","method":"Co-immunoprecipitation (competitive association NR2B vs TrkB), neurite outgrowth assay, phosphorylation assay","journal":"Journal of molecular neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP showing competitive binding with functional signaling readout, single lab","pmids":["30547417"],"is_preprint":false},{"year":2022,"finding":"MLL deficiency decreases H3K4me3 at the Rasgrf1 locus, suppressing Rasgrf1 expression; Rasgrf1 is essential for the GTP-bound active state of Kras and activation of Kras downstream pathways; RASGRF1 fusions (TMEM87A-RASGRF1, OCLN-RASGRF1, SLC4A4-RASGRF1, IQGAP1-RASGRF1) increase cellular GTP-RAS levels, induce cellular transformation, and promote in vivo tumorigenesis, with sensitivity to RAF-MEK-ERK pathway inhibition.","method":"Genetically engineered mouse models, ChIP-seq (H3K4me3), CRISPR-Cas9 edited cell lines, Ras-GTP pulldown, transformation assays, xenograft models, MEK inhibitor treatment","journal":"Cancer research / Clinical cancer research","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple independent labs, CRISPR engineering, in vitro and in vivo functional validation, mechanistic chromatin and signaling data","pmids":["36098964","35247929","32312893"],"is_preprint":false},{"year":2015,"finding":"VLDLR interacts with RasGRF1 (co-immunoprecipitation), and knockdown of RasGRF1 blocks VLDLR-induced increases in dendritic spine number in hippocampal neurons; VLDLR cannot rescue spine deficits caused by loss of CaMKIIα or CaMKIIβ, placing RasGRF1 downstream of VLDLR and requiring CaMKII for the VLDLR-RasGRF1 spinogenesis pathway.","method":"Co-immunoprecipitation, shRNA knockdown, dendritic spine morphology analysis in primary hippocampal cultures","journal":"Biochimica et biophysica acta","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — Co-IP and RNAi epistasis, defined morphological phenotype, single lab","pmids":["25644714"],"is_preprint":false},{"year":2008,"finding":"The N-terminal PHCCIQ region of RasGRF1 interacts with ribosomal proteins, cytoskeletal proteins, and proteins involved in vesicular trafficking from mouse brain extracts; the PHCCIQ domain exhibits RNA-binding properties, associating with poly(A)-containing RNA and ribosomal protein S6.","method":"Affinity purification with chitin-binding domain fusion, mass spectrometry, co-immunoprecipitation, poly(A)-Sepharose binding","journal":"Journal of molecular neuroscience","confidence":"Low","confidence_rationale":"Tier 3 / Weak — large-scale affinity pull-down with limited individual validation, single lab, no functional consequence established","pmids":["18607774"],"is_preprint":false},{"year":2025,"finding":"Matrix stiffness activates RasGRF1, leading to increased Ras-GTP levels and downstream activation of both AKT and ERK pathways; RasGRF1-dependent AKT activation leads to FOXO3a phosphorylation/inactivation and Bim degradation, promoting lung fibroblast survival on stiff substrates; RNAi depletion of FOXO3a or Bim recapitulates the survival phenotype.","method":"RNAi knockdown of RasGRF1, pharmacological AKT/ERK inhibitors, Ras-GTP pulldown assay, FOXO3a/Bim western blot, fibroblast survival assay on hydrogels of varying stiffness","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — RNAi with defined signaling and survival phenotype, multiple pathway inhibitors and downstream validation, single lab","pmids":["39793891"],"is_preprint":false}],"current_model":"RASGRF1 is a brain-enriched (but not exclusively neuronal) calcium/calmodulin-dependent guanine nucleotide exchange factor that activates H-Ras and Rac1 through distinct catalytic domains (CDC25/Cdc25 and DH, respectively); it couples NR2B-containing NMDA receptors to the Rac/p38 MAPK pathway promoting LTD, integrates dopamine and glutamate signals in striatal neurons via Ras-ERK to control synaptic plasticity and drug-induced behaviors, is activated by PKA-mediated phosphorylation at Ser916/898, forms a complex with CARD9 to link Dectin-1/Syk to H-Ras/ERK in innate immunity, is required for IGF-I-dependent beta-cell proliferation and survival signaling, and is regulated at the epigenetic level by piRNA-directed DMD methylation (paternal imprinting via CTCF-dependent enhancer blocking) that controls its tissue-specific monoallelic expression."},"narrative":{"mechanistic_narrative":"RASGRF1 is a calcium/calmodulin-regulated guanine nucleotide exchange factor that couples cell-surface receptors to small-GTPase signaling, acting on H-Ras through its Cdc25 domain and on Rac1 through its DH domain, with coordinated engagement of both activities required for its full morphological effects in neurons [PMID:7684828, PMID:16481401]. In the nervous system it is a dedicated effector of NR2B-containing NMDA receptors, binding the NR2B subunit (not NR2A or NR1) to drive NMDAR-dependent ERK activation and to route signaling toward the Rac/p38 MAPK cascade that promotes hippocampal LTD, dendritogenesis, and superoxide production via NOX2 [PMID:14622581, PMID:16467520, PMID:20107120, PMID:31245854]. Its catalytic output is gated by PKA-dependent phosphorylation at Ser916/898 (human Ser927), a regulatory node engaged downstream of muscarinic, Gs-coupled 5-HT7, and other receptors that is required for maximal GEF activity and Ras-dependent neurite outgrowth [PMID:10601308, PMID:12538592, PMID:15853814]. RASGRF1 integrates dopamine D1 and glutamate signals in striatal medium spiny neurons to activate Ras-ERK, controlling cocaine-induced behavioral plasticity and L-DOPA-induced dyskinesia [PMID:19446794, PMID:21115823]. Beyond neurons it links the Dectin-1/Syk/CARD9 module to H-Ras/ERK for antifungal cytokine responses [PMID:25267792, PMID:26521038], is required for IGF-I-dependent beta-cell proliferation and survival signaling [PMID:12805218], and supports Ras/ERK and AKT signaling driving tumorigenesis, including oncogenic RASGRF1 fusions that elevate GTP-RAS and confer RAF-MEK-ERK inhibitor sensitivity [PMID:22752028, PMID:36098964, PMID:35247929, PMID:32312893]. The locus is subject to paternal imprinting controlled by a CTCF-dependent, methylation-sensitive differentially methylated domain whose paternal methylation is established by a 3' direct repeat and the piRNA pathway [PMID:16314537, PMID:11753386, PMID:21566194].","teleology":[{"year":1993,"claim":"Established that the human gene encodes a functional Ras-specific guanine nucleotide-releasing factor, defining its core biochemical activity.","evidence":"In vitro GEF assay with recombinant protein, yeast complementation of cdc25/RAS2 mutants, and mammalian Ras-responsive reporter","pmids":["7684828"],"confidence":"High","gaps":["Did not address regulation by calcium/calmodulin or receptors","No cellular context or upstream activator identified"]},{"year":1999,"claim":"Identified PKA phosphorylation at Ser916 as a regulatory input linking cAMP signaling to RASGRF1 GEF activity, answering how receptor signals tune its catalysis.","evidence":"Site-directed mutagenesis, in vivo phosphorylation mapping, in vitro PKA kinase assay, and GEF activity readout downstream of muscarinic receptors","pmids":["10601308"],"confidence":"High","gaps":["PKA phosphorylation alone insufficient for activation; additional inputs unresolved","Structural basis of phospho-activation unknown"]},{"year":1999,"claim":"Showed RASGRF1 directly and specifically binds activated TrkA and is a TrkA substrate, providing a receptor tyrosine kinase entry point distinct from GPCRs.","evidence":"Yeast two-hybrid and in vitro kinase assay with TrkB/TrkC specificity comparisons","pmids":["10691301"],"confidence":"Medium","gaps":["Single-lab, no cellular functional consequence established","Tyr phosphosites on RASGRF1 not mapped"]},{"year":2002,"claim":"Defined how RASGRF1 biases output toward p38 by binding the IB2/JIP2 scaffold that assembles the MLK3-MKK3-p38 cassette.","evidence":"Co-immunoprecipitation and kinase activation assays in overexpression systems","pmids":["12024021"],"confidence":"Medium","gaps":["Single lab, largely overexpression-based","Endogenous scaffold complex stoichiometry unresolved"]},{"year":2003,"claim":"Identified the direct, subunit-specific NR2B–RASGRF1 interaction as the molecular link coupling NR2B-NMDARs to ERK.","evidence":"Reciprocal Co-IP in vivo and in vitro plus interaction-disrupting peptides in living neurons with ERK readout","pmids":["14622581"],"confidence":"High","gaps":["Binding interface on NR2B not mapped at residue level","How Ca2+ entry triggers complex remodeling unresolved"]},{"year":2003,"claim":"Extended PKA regulation to function, showing Ser916/898 phosphorylation is required for Ras-dependent neurite outgrowth and occurs on endogenous brain RASGRF1.","evidence":"Phospho-specific antibody, 32P labeling in brain slices, mutagenesis, and neurite outgrowth assays","pmids":["12538592"],"confidence":"High","gaps":["Upstream kinase activation in vivo context partial","Quantitative contribution of each site unresolved"]},{"year":2003,"claim":"Established a peripheral, non-neuronal role: RASGRF1 is required for IGF-I-driven Akt/Erk activation and beta-cell proliferation.","evidence":"Knockout mice, isolated islet IGF-I stimulation immunoblots, glucose tolerance, and histology","pmids":["12805218"],"confidence":"High","gaps":["Direct GEF coupling to the IGF-I receptor not demonstrated","Mechanism of IGF-I-dependent recruitment unknown"]},{"year":2005,"claim":"Resolved imprinting control: the DMD acts as a methylation-sensitive CTCF enhancer blocker dictating monoallelic expression.","evidence":"CTCF binding assays, in vitro and in vivo enhancer-blocking, and methylation analysis","pmids":["16314537"],"confidence":"High","gaps":["Tissue-specific enhancer targets not enumerated","Connection of imprinting to physiological RASGRF1 dosage incomplete"]},{"year":2005,"claim":"Showed Gs-coupled 5-HT7 receptors drive PKA phosphorylation of human RASGRF1 (Ser927) and that the Ca2+/calmodulin IQ domain is required for full ERK output.","evidence":"Phosphorylation and IQ-deletion mutant analysis with ERK immunoblot and Ca2+ measurement","pmids":["15853814"],"confidence":"Medium","gaps":["Single lab","Interplay between Ca2+/CaM and PKA inputs not quantitatively dissected"]},{"year":2006,"claim":"Genetically separated RASGRF1 from RASGRF2, assigning RASGRF1 to the NR2B–Rac–p38 LTD axis and RASGRF2 to the NR2A–ERK LTP axis.","evidence":"Ras-GRF1 and Ras-GRF2 knockout mice with electrophysiology and NMDAR-subtype pharmacology","pmids":["16467520"],"confidence":"High","gaps":["Molecular basis of effector selectivity not fully defined","Developmental timing dependence only partially characterized"]},{"year":2006,"claim":"Defined the dual-GEF architecture, showing distinct Cdc25 (H-Ras) and DH (Rac1) domains must act in concert, with H-Ras·GTP binding coupling to Rac via PI3K/Akt.","evidence":"Truncation mutants, bacterial-lysate pulldowns, HEK293 Co-IP, dominant-negative Rac1/RhoA, and morphological analysis","pmids":["16481401"],"confidence":"High","gaps":["Structural coupling between domains unresolved","How upstream signals choose H-Ras vs Rac output unclear"]},{"year":2006,"claim":"Identified SCLIP as a DH-domain binding partner that selectively dampens the Rac/p38 arm without affecting Ras/ERK, providing an effector-arm-specific brake.","evidence":"Yeast two-hybrid, Co-IP, pathway-specific activity assays, and neurite outgrowth in PC12 cells","pmids":["17135267"],"confidence":"Medium","gaps":["Single lab","In vivo relevance of SCLIP regulation not tested"]},{"year":2007,"claim":"Showed RASGRF1 abundance is controlled post-translationally, with Filamin A driving its ubiquitylation and destabilization to limit H-Ras/ERK and MMP-9 in melanoma.","evidence":"Ubiquitylation assay, MMP-9 reporter, dominant-negative and ectopic RASGRF1, and kinase assays","pmids":["17389601"],"confidence":"Medium","gaps":["E3 ligase mediating ubiquitylation not identified","Single lab"]},{"year":2009,"claim":"Placed RASGRF1 as the integrator of dopamine D1 and glutamate signals driving striatal ERK and cocaine-related behaviors.","evidence":"Knockout and overexpressing mice, striatal cultures/slices, pERK assays, and behavioral tests","pmids":["19446794"],"confidence":"High","gaps":["Molecular coupling of D1/cAMP to RASGRF1 in MSNs only partly defined","Circuit specificity not fully resolved"]},{"year":2010,"claim":"Demonstrated therapeutic relevance: striatal dominant-negative RASGRF1 reverses L-DOPA-induced dyskinesia in primates, establishing causal requirement of RASGRF1-Ras-ERK signaling.","evidence":"Knockout mice plus lentiviral dominant-negative RASGRF1 in a non-human primate model with AIMs scoring","pmids":["21115823"],"confidence":"High","gaps":["Downstream ERK targets mediating dyskinesia not identified","Long-term consequences of striatal RASGRF1 inhibition unknown"]},{"year":2010,"claim":"Showed the NR2B–RASGRF1 interaction is required for NR2B-driven dendritic branch formation, linking the complex to neuronal morphogenesis.","evidence":"Interaction-disrupting mutants, NR2-null neurons reconstituted with NR2A/NR2B, dendritic morphology, and electrophysiology","pmids":["20107120"],"confidence":"Medium","gaps":["Single lab","Downstream effector arm for dendritogenesis not specified here"]},{"year":2011,"claim":"Revealed the mechanism establishing paternal DMD methylation: piRNAs targeting a retrotransposon within a DMD-spanning noncoding RNA, with the direct repeat acting as its promoter.","evidence":"Mili/Miwi2 knockout mice, bisulfite sequencing, and RNA analysis","pmids":["21566194"],"confidence":"High","gaps":["How piRNA-guided complexes recruit de novo methyltransferases at this locus not fully detailed","Generality across tissues not addressed"]},{"year":2001,"claim":"Identified the 3' direct repeat as the germ-line element required to establish paternal DMD methylation and imprinted expression.","evidence":"Targeted repeat deletion in mice, bisulfite methylation, and allele-specific expression analysis","pmids":["11753386"],"confidence":"High","gaps":["Mechanism by which the repeat directs methylation only later resolved","Trans-acting factors not identified at this stage"]},{"year":2012,"claim":"Showed transcriptional control of Rasgrf1 by Zac1/Plagl1 in beta cells, linking its dosage to insulin secretion and MAPK/PI3K signaling.","evidence":"Overexpression and rescue in beta cells, pathway and insulin secretion assays, and diabetic transplantation model","pmids":["22547676"],"confidence":"Medium","gaps":["Direct vs indirect repression mechanism partly defined","Single lab"]},{"year":2012,"claim":"Established RASGRF1 as required for Ras/ERK and AKT signaling downstream of pro-metastatic ligands and for rhabdomyosarcoma tumor growth.","evidence":"shRNA knockdown, MAPK/AKT phosphorylation, chemotaxis, and xenograft tumor assays","pmids":["22752028"],"confidence":"Medium","gaps":["Receptor coupling mechanism to RASGRF1 not defined","Single lab"]},{"year":2014,"claim":"Identified the CARD9–RASGRF1 complex linking Dectin-1/Syk to H-Ras/ERK in antifungal innate immunity.","evidence":"Co-IP, phosphorylation assays, CARD9 KO cells, ERK readout, and an in vivo infection model","pmids":["25267792"],"confidence":"High","gaps":["Syk phosphosites on RASGRF1 not mapped","How phosphorylation enables CARD9/H-Ras recruitment unresolved"]},{"year":2014,"claim":"Demonstrated a cell-autonomous role for RASGRF1 in adult hippocampal neurogenesis, promoting dendritic arborization and survival of young neurons.","evidence":"Knockout mice, BrdU labeling, and retroviral shRNA in new neurons with morphology analysis","pmids":["24174283"],"confidence":"Medium","gaps":["Upstream activators in new neurons not defined","Age-dependence mechanism unresolved"]},{"year":2015,"claim":"Confirmed disease relevance of the CARD9-RASGRF1 axis: a CARD9 Y91H mutation selectively impairs RASGRF1 binding, ERK/NF-κB activation, and GM-CSF responses.","evidence":"Co-IP and signaling/cytokine assays in patient-derived monocytes with CARD9 mutant analysis","pmids":["26521038"],"confidence":"Medium","gaps":["Single lab","Structural basis of selective RASGRF1 binding loss not defined"]},{"year":2015,"claim":"Placed RASGRF1 downstream of VLDLR in CaMKII-dependent dendritic spinogenesis.","evidence":"Co-IP, shRNA knockdown, and spine morphology in hippocampal cultures","pmids":["25644714"],"confidence":"Medium","gaps":["Single lab; epistasis-based positioning","Directness of VLDLR-RASGRF1 coupling unclear"]},{"year":2018,"claim":"Expanded substrate range, showing RASGRF1 acts as a GEF for R-Ras in BDNF-induced axonal growth, with PKA Ser916/898 phosphorylation required.","evidence":"RNAi, overexpression, R-Ras pulldown, axonal morphology, and phosphorylation assays","pmids":["30582008"],"confidence":"Medium","gaps":["Single lab","Direct R-Ras GEF kinetics not measured"]},{"year":2018,"claim":"Showed receptor competition controls RASGRF1 targeting: TrkB/BDNF recruits RASGRF1 away from NR2B toward TrkB, biasing toward ERK and away from LTD.","evidence":"Competitive Co-IP, phosphorylation, and neurite outgrowth assays","pmids":["30547417"],"confidence":"Medium","gaps":["Single lab","In vivo significance of the switch not tested"]},{"year":2019,"claim":"Defined an effector branch downstream of the NR2B–RASGRF1 complex, showing it drives NOX2-dependent superoxide required for dendritogenesis.","evidence":"DHE superoxide detection, interaction-disrupting peptide, and dendritic branching analysis","pmids":["31245854"],"confidence":"Medium","gaps":["Single lab","Mechanism coupling RASGRF1 to NOX2 not defined"]},{"year":2022,"claim":"Established RASGRF1 as a chromatin-regulated, oncogenic driver: MLL/H3K4me3 controls its expression, it is required for active GTP-Kras, and RASGRF1 fusions transform cells with RAF-MEK-ERK inhibitor sensitivity.","evidence":"GEMMs, ChIP-seq, CRISPR-edited cells, Ras-GTP pulldown, transformation and xenograft assays, MEK inhibitor treatment (multiple labs)","pmids":["36098964","35247929","32312893"],"confidence":"High","gaps":["Whether fusion proteins retain calcium/PKA regulation unresolved","Structural basis of fusion-driven GEF activation undefined"]},{"year":2025,"claim":"Showed RASGRF1 functions as a mechanosensitive activator, transducing matrix stiffness into Ras-GTP, AKT-FOXO3a-Bim survival signaling in lung fibroblasts.","evidence":"RNAi, AKT/ERK inhibitors, Ras-GTP pulldown, FOXO3a/Bim immunoblots, and fibroblast survival assays on variable-stiffness hydrogels","pmids":["39793891"],"confidence":"Medium","gaps":["Single lab","Mechanosensing mechanism upstream of RASGRF1 not defined"]},{"year":null,"claim":"How RASGRF1 integrates its Ca2+/calmodulin, PKA, and tyrosine-kinase inputs at the structural level to select between H-Ras, R-Ras, and Rac1 outputs in a given cell type remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structural model of full-length regulated RASGRF1","Quantitative rules governing effector selection unknown","Whether oncogenic fusions bypass normal regulatory inputs untested"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[9,6,24]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[9,6,26]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[0,3]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,3]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[6]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[9,6,0]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[1,13,19]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[3,20]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[26,21]}],"complexes":[],"partners":["GRIN2B","CARD9","H-RAS","RAC1","NTRK1","NTRK2","FLNA","VLDLR"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q13972","full_name":"Ras-specific guanine nucleotide-releasing factor 1","aliases":["Guanine nucleotide-releasing protein","GNRP","Ras-specific nucleotide exchange factor CDC25"],"length_aa":1273,"mass_kda":145.2,"function":"Promotes the exchange of Ras-bound GDP by GTP","subcellular_location":"","url":"https://www.uniprot.org/uniprotkb/Q13972/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/RASGRF1","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/RASGRF1","total_profiled":1310},"omim":[{"mim_id":"619038","title":"SPOC DOMAIN-CONTAINING PROTEIN 1; SPOCD1","url":"https://www.omim.org/entry/619038"},{"mim_id":"606614","title":"RAS PROTEIN-SPECIFIC GUANINE NUCLEOTIDE-RELEASING FACTOR 2; RASGRF2","url":"https://www.omim.org/entry/606614"},{"mim_id":"606600","title":"RAS PROTEIN-SPECIFIC GUANINE NUCLEOTIDE-RELEASING FACTOR 1; RASGRF1","url":"https://www.omim.org/entry/606600"},{"mim_id":"600303","title":"RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 1; RAPGEF1","url":"https://www.omim.org/entry/600303"},{"mim_id":"189940","title":"TRANSLOCATED PROMOTER REGION; TPR","url":"https://www.omim.org/entry/189940"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Golgi apparatus","reliability":"Approved"}],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"brain","ntpm":51.5}],"url":"https://www.proteinatlas.org/search/RASGRF1"},"hgnc":{"alias_symbol":["CDC25L","CDC25","GRF55","H-GRF55","GNRP","PP13187"],"prev_symbol":["GRF1"]},"alphafold":{"accession":"Q13972","domains":[{"cath_id":"2.30.29.30","chopping":"10-79_92-129","consensus_level":"medium","plddt":83.0744,"start":10,"end":129},{"cath_id":"1.20.900.10","chopping":"234-431","consensus_level":"high","plddt":90.5999,"start":234,"end":431},{"cath_id":"2.30.29.30","chopping":"459-468_489-528_547-598","consensus_level":"high","plddt":78.2105,"start":459,"end":598},{"cath_id":"1.10.840.10","chopping":"1032-1187_1235-1268","consensus_level":"high","plddt":93.6228,"start":1032,"end":1268}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q13972","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q13972-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q13972-F1-predicted_aligned_error_v6.png","plddt_mean":72.0},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=RASGRF1","jax_strain_url":"https://www.jax.org/strain/search?query=RASGRF1"},"sequence":{"accession":"Q13972","fasta_url":"https://rest.uniprot.org/uniprotkb/Q13972.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q13972/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q13972"}},"corpus_meta":[{"pmid":"14622581","id":"PMC_14622581","title":"The NMDA receptor is coupled to the ERK pathway by a direct interaction between NR2B and RasGRF1.","date":"2003","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/14622581","citation_count":372,"is_preprint":false},{"pmid":"21566194","id":"PMC_21566194","title":"Role for piRNAs and noncoding RNA in de novo DNA methylation of the imprinted mouse Rasgrf1 locus.","date":"2011","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/21566194","citation_count":303,"is_preprint":false},{"pmid":"12024021","id":"PMC_12024021","title":"Interaction of Rac exchange factors Tiam1 and Ras-GRF1 with a scaffold for the p38 mitogen-activated protein kinase cascade.","date":"2002","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/12024021","citation_count":163,"is_preprint":false},{"pmid":"16467520","id":"PMC_16467520","title":"Distinct roles for Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) and Ras-GRF2 in the induction of long-term potentiation and long-term depression.","date":"2006","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/16467520","citation_count":150,"is_preprint":false},{"pmid":"21115823","id":"PMC_21115823","title":"Inhibition of Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) signaling in the striatum reverts motor symptoms associated with L-dopa-induced dyskinesia.","date":"2010","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/21115823","citation_count":132,"is_preprint":false},{"pmid":"11753386","id":"PMC_11753386","title":"Regulation of DNA methylation of Rasgrf1.","date":"2001","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11753386","citation_count":131,"is_preprint":false},{"pmid":"25267792","id":"PMC_25267792","title":"CARD9 mediates Dectin-1-induced ERK activation by linking Ras-GRF1 to H-Ras for antifungal immunity.","date":"2014","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/25267792","citation_count":119,"is_preprint":false},{"pmid":"11640934","id":"PMC_11640934","title":"Hippocampus-dependent learning and memory is impaired in mice lacking the Ras-guanine-nucleotide releasing factor 1 (Ras-GRF1).","date":"2001","source":"Neuropharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/11640934","citation_count":117,"is_preprint":false},{"pmid":"18670629","id":"PMC_18670629","title":"Antagonism between DNA and H3K27 methylation at the imprinted Rasgrf1 locus.","date":"2008","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18670629","citation_count":97,"is_preprint":false},{"pmid":"19446794","id":"PMC_19446794","title":"Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) controls activation of extracellular signal-regulated kinase (ERK) signaling in the striatum and long-term behavioral responses to cocaine.","date":"2009","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/19446794","citation_count":85,"is_preprint":false},{"pmid":"16314537","id":"PMC_16314537","title":"Rasgrf1 imprinting is regulated by a CTCF-dependent methylation-sensitive enhancer blocker.","date":"2005","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16314537","citation_count":83,"is_preprint":false},{"pmid":"22371710","id":"PMC_22371710","title":"The effect of preconception paternal alcohol exposure on epigenetic remodeling of the h19 and rasgrf1 imprinting control regions in mouse offspring.","date":"2012","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22371710","citation_count":77,"is_preprint":false},{"pmid":"26521038","id":"PMC_26521038","title":"Impaired RASGRF1/ERK-mediated GM-CSF response characterizes CARD9 deficiency in French-Canadians.","date":"2015","source":"The Journal of allergy and clinical immunology","url":"https://pubmed.ncbi.nlm.nih.gov/26521038","citation_count":70,"is_preprint":false},{"pmid":"12805218","id":"PMC_12805218","title":"Ras-GRF1 signaling is required for normal beta-cell development and glucose homeostasis.","date":"2003","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/12805218","citation_count":68,"is_preprint":false},{"pmid":"20107120","id":"PMC_20107120","title":"Differential roles of NMDA Receptor Subtypes NR2A and NR2B in dendritic branch development and requirement of RasGRF1.","date":"2010","source":"Journal of neurophysiology","url":"https://pubmed.ncbi.nlm.nih.gov/20107120","citation_count":66,"is_preprint":false},{"pmid":"24844602","id":"PMC_24844602","title":"Derangement of Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) and extracellular signal-regulated kinase (ERK) dependent striatal plasticity in L-DOPA-induced dyskinesia.","date":"2014","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/24844602","citation_count":60,"is_preprint":false},{"pmid":"21422498","id":"PMC_21422498","title":"RasGrf1 deficiency delays aging in mice.","date":"2011","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/21422498","citation_count":50,"is_preprint":false},{"pmid":"17389601","id":"PMC_17389601","title":"Filamin A-mediated down-regulation of the exchange factor Ras-GRF1 correlates with decreased matrix metalloproteinase-9 expression in human melanoma cells.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17389601","citation_count":49,"is_preprint":false},{"pmid":"9933566","id":"PMC_9933566","title":"A direct repeat sequence at the Rasgrf1 locus and imprinted expression.","date":"1999","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/9933566","citation_count":44,"is_preprint":false},{"pmid":"7684828","id":"PMC_7684828","title":"Identification of a human guanine nucleotide-releasing factor (H-GRF55) specific for Ras proteins.","date":"1993","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/7684828","citation_count":44,"is_preprint":false},{"pmid":"19457086","id":"PMC_19457086","title":"RasGRF1 disruption causes retinal photoreception defects and associated transcriptomic alterations.","date":"2009","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19457086","citation_count":38,"is_preprint":false},{"pmid":"10691301","id":"PMC_10691301","title":"Activity-dependent interaction of the intracellular domain of rat trkA with intermediate filament proteins, the beta-6 proteasomal subunit, Ras-GRF1, and the p162 subunit of eIF3.","date":"1999","source":"Journal of molecular neuroscience : MN","url":"https://pubmed.ncbi.nlm.nih.gov/10691301","citation_count":38,"is_preprint":false},{"pmid":"12538592","id":"PMC_12538592","title":"Phosphorylation of the Ras-GRF1 exchange factor at Ser916/898 reveals activation of Ras signaling in the cerebral cortex.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12538592","citation_count":34,"is_preprint":false},{"pmid":"22961779","id":"PMC_22961779","title":"Aberrant methylation of RASGRF1 is associated with an epigenetic field defect and increased risk of gastric cancer.","date":"2012","source":"Cancer prevention research (Philadelphia, Pa.)","url":"https://pubmed.ncbi.nlm.nih.gov/22961779","citation_count":33,"is_preprint":false},{"pmid":"18584336","id":"PMC_18584336","title":"Transcriptomic and proteomic analyses of mouse cerebellum reveals alterations in RasGRF1 expression following in vivo chronic treatment with delta 9-tetrahydrocannabinol.","date":"2008","source":"Journal of molecular neuroscience : MN","url":"https://pubmed.ncbi.nlm.nih.gov/18584336","citation_count":31,"is_preprint":false},{"pmid":"15853814","id":"PMC_15853814","title":"Endogenous expression and protein kinase A-dependent phosphorylation of the guanine nucleotide exchange factor Ras-GRF1 in human embryonic kidney 293 cells.","date":"2005","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/15853814","citation_count":30,"is_preprint":false},{"pmid":"19513790","id":"PMC_19513790","title":"Imprint switch mutations at Rasgrf1 support conflict hypothesis of imprinting and define a growth control mechanism upstream of IGF1.","date":"2009","source":"Mammalian genome : official journal of the International Mammalian Genome Society","url":"https://pubmed.ncbi.nlm.nih.gov/19513790","citation_count":30,"is_preprint":false},{"pmid":"22164138","id":"PMC_22164138","title":"Mice Lacking Ras-GRF1 Show Contextual Fear Conditioning but not Spatial Memory Impairments: Convergent Evidence from Two Independently Generated Mouse Mutant Lines.","date":"2011","source":"Frontiers in behavioral neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/22164138","citation_count":30,"is_preprint":false},{"pmid":"12095702","id":"PMC_12095702","title":"Structural characterization of Rasgrf1 and a novel linked imprinted locus.","date":"2002","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/12095702","citation_count":29,"is_preprint":false},{"pmid":"12925882","id":"PMC_12925882","title":"Two ENU-induced mutations in Rasgrf1 and early mouse growth retardation.","date":"2003","source":"Mammalian genome : official journal of the International Mammalian Genome Society","url":"https://pubmed.ncbi.nlm.nih.gov/12925882","citation_count":28,"is_preprint":false},{"pmid":"21765200","id":"PMC_21765200","title":"RasGrf1: genomic imprinting, VSELs, and aging.","date":"2011","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/21765200","citation_count":26,"is_preprint":false},{"pmid":"22547676","id":"PMC_22547676","title":"Transient neonatal diabetes mellitus gene Zac1 impairs insulin secretion in mice through Rasgrf1.","date":"2012","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/22547676","citation_count":26,"is_preprint":false},{"pmid":"16481401","id":"PMC_16481401","title":"The Ras-GRF1 exchange factor coordinates activation of H-Ras and Rac1 to control neuronal morphology.","date":"2006","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/16481401","citation_count":26,"is_preprint":false},{"pmid":"10601308","id":"PMC_10601308","title":"Phosphorylation of serine 916 of Ras-GRF1 contributes to the activation of exchange factor activity by muscarinic receptors.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10601308","citation_count":26,"is_preprint":false},{"pmid":"17030618","id":"PMC_17030618","title":"Timing and sequence requirements defined for embryonic maintenance of imprinted DNA methylation at Rasgrf1.","date":"2006","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/17030618","citation_count":24,"is_preprint":false},{"pmid":"22752028","id":"PMC_22752028","title":"RasGRF1 regulates proliferation and metastatic behavior of human alveolar rhabdomyosarcomas.","date":"2012","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/22752028","citation_count":22,"is_preprint":false},{"pmid":"19678938","id":"PMC_19678938","title":"The Ras guanine nucleotide exchange factor RasGRF1 promotes matrix metalloproteinase-3 production in rheumatoid arthritis synovial tissue.","date":"2009","source":"Arthritis research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/19678938","citation_count":20,"is_preprint":false},{"pmid":"26440052","id":"PMC_26440052","title":"miR-137 acts as a tumor suppressor in astrocytoma by targeting RASGRF1.","date":"2015","source":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/26440052","citation_count":20,"is_preprint":false},{"pmid":"25644714","id":"PMC_25644714","title":"Very low density lipoprotein receptor regulates dendritic spine formation in a RasGRF1/CaMKII dependent manner.","date":"2015","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/25644714","citation_count":20,"is_preprint":false},{"pmid":"32312893","id":"PMC_32312893","title":"Identification of a RAS-activating TMEM87A-RASGRF1 Fusion in an Exceptional Responder to Sunitinib with Non-Small Cell Lung Cancer.","date":"2020","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/32312893","citation_count":20,"is_preprint":false},{"pmid":"30308936","id":"PMC_30308936","title":"Deletion of RasGRF1 Attenuated Interstitial Fibrosis in Streptozotocin-Induced Diabetic Cardiomyopathy in Mice through Affecting Inflammation and Oxidative Stress.","date":"2018","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/30308936","citation_count":19,"is_preprint":false},{"pmid":"21620943","id":"PMC_21620943","title":"Novel RasGRF1-derived Tat-fused peptides inhibiting Ras-dependent proliferation and migration in mouse and human cancer cells.","date":"2011","source":"Biotechnology advances","url":"https://pubmed.ncbi.nlm.nih.gov/21620943","citation_count":17,"is_preprint":false},{"pmid":"26890742","id":"PMC_26890742","title":"A Mercaptoacetamide-Based Class II Histone Deacetylase Inhibitor Increases Dendritic Spine Density via RasGRF1/ERK Pathway.","date":"2016","source":"Journal of Alzheimer's disease : JAD","url":"https://pubmed.ncbi.nlm.nih.gov/26890742","citation_count":17,"is_preprint":false},{"pmid":"24808846","id":"PMC_24808846","title":"Genetic variation of the RASGRF1 regulatory region affects human hippocampus-dependent memory.","date":"2014","source":"Frontiers in human neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/24808846","citation_count":17,"is_preprint":false},{"pmid":"19502804","id":"PMC_19502804","title":"Differential methylation persists at the mouse Rasgrf1 DMR in tissues displaying monoallelic and biallelic expression.","date":"2009","source":"Epigenetics","url":"https://pubmed.ncbi.nlm.nih.gov/19502804","citation_count":17,"is_preprint":false},{"pmid":"26125041","id":"PMC_26125041","title":"Differential involvement of Ras-GRF1 and Ras-GRF2 in L-DOPA-induced dyskinesia.","date":"2015","source":"Annals of clinical and translational neurology","url":"https://pubmed.ncbi.nlm.nih.gov/26125041","citation_count":17,"is_preprint":false},{"pmid":"36098964","id":"PMC_36098964","title":"Loss of MLL Induces Epigenetic Dysregulation of Rasgrf1 to Attenuate Kras-Driven Lung Tumorigenesis.","date":"2022","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/36098964","citation_count":16,"is_preprint":false},{"pmid":"17135267","id":"PMC_17135267","title":"SCLIP, a microtubule-destabilizing factor, interacts with RasGRF1 and inhibits its ability to promote Rac activation and neurite outgrowth.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17135267","citation_count":16,"is_preprint":false},{"pmid":"35247929","id":"PMC_35247929","title":"RASGRF1 Fusions Activate Oncogenic RAS Signaling and Confer Sensitivity to MEK Inhibition.","date":"2022","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/35247929","citation_count":14,"is_preprint":false},{"pmid":"21251221","id":"PMC_21251221","title":"Imprinted Rasgrf1 expression in neonatal mice affects olfactory learning and memory.","date":"2011","source":"Genes, brain, and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/21251221","citation_count":14,"is_preprint":false},{"pmid":"23834555","id":"PMC_23834555","title":"Evaluating the association between pathological myopia and SNPs in RASGRF1. ACTC1 and GJD2 genes at chromosome 15q14 and 15q25 in a Chinese population.","date":"2013","source":"Ophthalmic genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23834555","citation_count":14,"is_preprint":false},{"pmid":"23200899","id":"PMC_23200899","title":"Decreased expression of Ras-GRF1 in the brain tissue of the intractable epilepsy patients and experimental rats.","date":"2012","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/23200899","citation_count":14,"is_preprint":false},{"pmid":"24174283","id":"PMC_24174283","title":"Age-dependent role for Ras-GRF1 in the late stages of adult neurogenesis in the dentate gyrus.","date":"2014","source":"Hippocampus","url":"https://pubmed.ncbi.nlm.nih.gov/24174283","citation_count":14,"is_preprint":false},{"pmid":"40355406","id":"PMC_40355406","title":"IGF2BP3-mediated m6A modification of RASGRF1 promoting joint injury in rheumatoid arthritis.","date":"2025","source":"Bone research","url":"https://pubmed.ncbi.nlm.nih.gov/40355406","citation_count":13,"is_preprint":false},{"pmid":"26644762","id":"PMC_26644762","title":"Polymorphism in the RASGRF1 gene with high myopia: A meta-analysis.","date":"2015","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/26644762","citation_count":13,"is_preprint":false},{"pmid":"29530990","id":"PMC_29530990","title":"RASGRF1 Hypermethylation, a Putative Biomarker of Colorectal Cancer.","date":"2018","source":"Annals of clinical and laboratory science","url":"https://pubmed.ncbi.nlm.nih.gov/29530990","citation_count":13,"is_preprint":false},{"pmid":"34799483","id":"PMC_34799483","title":"RASGRF1-rearranged Cutaneous Melanocytic Neoplasms With Spitzoid Cytomorphology: A Clinicopathologic and Genetic Study of 3 Cases.","date":"2022","source":"The American journal of surgical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/34799483","citation_count":13,"is_preprint":false},{"pmid":"28611277","id":"PMC_28611277","title":"Association of RASgrf1 methylation with epileptic seizures.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/28611277","citation_count":12,"is_preprint":false},{"pmid":"31182637","id":"PMC_31182637","title":"The Inhibition of RasGRF2, But Not RasGRF1, Alters Cocaine Reward in Mice.","date":"2019","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/31182637","citation_count":12,"is_preprint":false},{"pmid":"22744634","id":"PMC_22744634","title":"Ras guanine nucleotide releasing factor 1 (RasGrf1) enhancement of Trk receptor-mediated neurite outgrowth requires activation of both H-Ras and Rac.","date":"2012","source":"Journal of molecular neuroscience : MN","url":"https://pubmed.ncbi.nlm.nih.gov/22744634","citation_count":12,"is_preprint":false},{"pmid":"25421944","id":"PMC_25421944","title":"Transcriptional profiling reveals functional links between RasGrf1 and Pttg1 in pancreatic beta cells.","date":"2014","source":"BMC genomics","url":"https://pubmed.ncbi.nlm.nih.gov/25421944","citation_count":11,"is_preprint":false},{"pmid":"21072176","id":"PMC_21072176","title":"A non-coding RNA within the Rasgrf1 locus in mouse is imprinted and regulated by its homologous chromosome in trans.","date":"2010","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21072176","citation_count":11,"is_preprint":false},{"pmid":"31245854","id":"PMC_31245854","title":"Superoxide generation via the NR2B-NMDAR/RasGRF1/NOX2 pathway promotes dendritogenesis.","date":"2019","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/31245854","citation_count":10,"is_preprint":false},{"pmid":"29793445","id":"PMC_29793445","title":"Heritability of myopia and its relation with GDJ2 and RASGRF1 genes in Lithuania.","date":"2018","source":"BMC ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/29793445","citation_count":10,"is_preprint":false},{"pmid":"30259712","id":"PMC_30259712","title":"Spatial learning and long-term memory impairments in RasGrf1 KO, Pttg1 KO, and double KO mice.","date":"2018","source":"Brain and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/30259712","citation_count":10,"is_preprint":false},{"pmid":"30582008","id":"PMC_30582008","title":"RasGRF1 mediates brain-derived neurotrophic factor-induced axonal growth in primary cultured cortical neurons.","date":"2018","source":"Biochemistry and biophysics reports","url":"https://pubmed.ncbi.nlm.nih.gov/30582008","citation_count":10,"is_preprint":false},{"pmid":"32473965","id":"PMC_32473965","title":"RasGRF1 participates in the protective effect of tanshinone IIA on depressive like behaviors of a chronic unpredictable mild stress induced mouse model.","date":"2020","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/32473965","citation_count":10,"is_preprint":false},{"pmid":"26675527","id":"PMC_26675527","title":"Hexa (ethylene glycol) derivative of benzothiazole aniline promotes dendritic spine formation through the RasGRF1-Ras dependent pathway.","date":"2015","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/26675527","citation_count":9,"is_preprint":false},{"pmid":"11602354","id":"PMC_11602354","title":"An expressed GNRP-like gene shares a bi-directional promoter with SF3A2 (SAP62) immediately upstream of AMH.","date":"2001","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/11602354","citation_count":8,"is_preprint":false},{"pmid":"24597981","id":"PMC_24597981","title":"Amplification of B cell receptor-Erk signaling by Rasgrf-1 overexpression in chronic lymphocytic leukemia.","date":"2014","source":"Leukemia & lymphoma","url":"https://pubmed.ncbi.nlm.nih.gov/24597981","citation_count":8,"is_preprint":false},{"pmid":"22470404","id":"PMC_22470404","title":"No Evidence for a Parent-of-Origin Specific Differentially Methylated Region Linked to RASGRF1.","date":"2012","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22470404","citation_count":7,"is_preprint":false},{"pmid":"31943943","id":"PMC_31943943","title":"Benzothiazole amphiphiles promote RasGRF1-associated dendritic spine formation in human stem cell-derived neurons.","date":"2020","source":"FEBS open bio","url":"https://pubmed.ncbi.nlm.nih.gov/31943943","citation_count":7,"is_preprint":false},{"pmid":"21182853","id":"PMC_21182853","title":"Paternal genome effects on aging: evidence for a role of Rasgrf1 in longevity determination?","date":"2010","source":"Mechanisms of ageing and development","url":"https://pubmed.ncbi.nlm.nih.gov/21182853","citation_count":7,"is_preprint":false},{"pmid":"30547417","id":"PMC_30547417","title":"TrkB Regulates N-Methyl-D-Aspartate Receptor Signaling by Uncoupling and Recruiting the Brain-Specific Guanine Nucleotide Exchange Factor, RasGrf1.","date":"2018","source":"Journal of molecular neuroscience : MN","url":"https://pubmed.ncbi.nlm.nih.gov/30547417","citation_count":6,"is_preprint":false},{"pmid":"27723119","id":"PMC_27723119","title":"Rasgrf1 mRNA expression in myopic eyes of guinea pigs.","date":"2016","source":"Clinical & experimental optometry","url":"https://pubmed.ncbi.nlm.nih.gov/27723119","citation_count":5,"is_preprint":false},{"pmid":"36064116","id":"PMC_36064116","title":"Median Nerve Stimulation Attenuates Traumatic Brain Injury-Induced Comatose State by Regulating the Orexin-A/RasGRF1 Signaling Pathway.","date":"2022","source":"World neurosurgery","url":"https://pubmed.ncbi.nlm.nih.gov/36064116","citation_count":5,"is_preprint":false},{"pmid":"30242550","id":"PMC_30242550","title":"RASgrf1, a Potential Methylatic Mediator of Anti-epileptogenesis?","date":"2018","source":"Neurochemical research","url":"https://pubmed.ncbi.nlm.nih.gov/30242550","citation_count":4,"is_preprint":false},{"pmid":"39793891","id":"PMC_39793891","title":"ECM stiffness regulates lung fibroblast survival through RasGRF1-dependent signaling.","date":"2025","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/39793891","citation_count":4,"is_preprint":false},{"pmid":"37053022","id":"PMC_37053022","title":"Upregulation of RasGRF1 ameliorates spatial cognitive dysfunction in mice after chronic cerebral hypoperfusion.","date":"2023","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/37053022","citation_count":3,"is_preprint":false},{"pmid":"40760370","id":"PMC_40760370","title":"FTO-mediated the destabilization of RASGRF1 mRNA impedes thyroid cancer progression and suppresses macrophage M2 polarization.","date":"2025","source":"Cell biology and toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/40760370","citation_count":3,"is_preprint":false},{"pmid":"24342659","id":"PMC_24342659","title":"Expression and genomic imprinting of the porcine Rasgrf1 gene.","date":"2013","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/24342659","citation_count":3,"is_preprint":false},{"pmid":"18607774","id":"PMC_18607774","title":"Identification of novel RasGRF1 interacting partners by large-scale proteomic analysis.","date":"2008","source":"Journal of molecular neuroscience : MN","url":"https://pubmed.ncbi.nlm.nih.gov/18607774","citation_count":3,"is_preprint":false},{"pmid":"34832880","id":"PMC_34832880","title":"A Rational Design of α-Helix-Shaped Peptides Employing the Hydrogen-Bond Surrogate Approach: A Modulation Strategy for Ras-RasGRF1 Interaction in Neuropsychiatric Disorders.","date":"2021","source":"Pharmaceuticals (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/34832880","citation_count":3,"is_preprint":false},{"pmid":"36864897","id":"PMC_36864897","title":"Correlation between High Myopia Susceptibility and Polymorphisms of RASGRF1 Gene among College Students in Zhejiang.","date":"2023","source":"Journal of environmental and public health","url":"https://pubmed.ncbi.nlm.nih.gov/36864897","citation_count":2,"is_preprint":false},{"pmid":"39841298","id":"PMC_39841298","title":"LINC02418 suppresses endometrial cancer progression via regulating miR-494-3p/RASGRF1 axis.","date":"2025","source":"Journal of molecular histology","url":"https://pubmed.ncbi.nlm.nih.gov/39841298","citation_count":2,"is_preprint":false},{"pmid":"38125881","id":"PMC_38125881","title":"Retracted: Correlation between High Myopia Susceptibility and Polymorphisms of RASGRF1 Gene among College Students in Zhejiang.","date":"2023","source":"Journal of environmental and public health","url":"https://pubmed.ncbi.nlm.nih.gov/38125881","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":46232,"output_tokens":7849,"usd":0.128216,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":17101,"output_tokens":7463,"usd":0.13604,"stage2_stop_reason":"end_turn"},"total_usd":0.264256,"stage1_batch_id":"msgbatch_01CNoDbkChHEkgrJnL7BwtGJ","stage2_batch_id":"msgbatch_016Y4x9E9Wg5VQDANj9quSQD","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2003,\n      \"finding\": \"RasGRF1 directly interacts with the NR2B subunit (but not NR2A or NR1) of NMDA receptors in vivo and in vitro; specific disruption of this interaction in living neurons abrogates NMDAR-dependent ERK activation, establishing RasGRF1 as the Ca2+/calmodulin-dependent regulator linking NR2B-containing NMDARs to the ERK kinase pathway.\",\n      \"method\": \"Co-immunoprecipitation (in vivo and in vitro), disruption peptides in living neurons, ERK activation assays\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP in vivo and in vitro, functional disruption in live neurons, replicated across multiple experimental contexts\",\n      \"pmids\": [\"14622581\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Ras-GRF1 mediates signaling from NR2B-containing NMDARs to the Rac effector p38 MAP kinase to promote long-term depression (LTD) in the CA1 hippocampus of postpubescent mice, while Ras-GRF2 (not Ras-GRF1) mediates signaling from NR2A-containing NMDARs to ERK1/2 to promote LTP.\",\n      \"method\": \"Genetic knockout mice (Ras-GRF1 KO, Ras-GRF2 KO), electrophysiology (LTP/LTD), pharmacological receptor subtype blockade (ifenprodil, NVP-AAM077)\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean KO with defined synaptic plasticity phenotype, pharmacological dissection of NMDAR subtypes, multiple orthogonal methods\",\n      \"pmids\": [\"16467520\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"The N-terminal region of Ras-GRF1 (containing PH domain, coiled-coil, and adjacent sequences) binds to the scaffold protein IB2/JIP2, which scaffolds the p38 MAP kinase cascade (MLK3-MKK3-p38); Ras-GRF1 binding to IB2/JIP2 selectively potentiates p38 activation but not JNK activation and increases assembly of the p38 signaling cassette.\",\n      \"method\": \"Co-immunoprecipitation, overexpression in cells, kinase activation assays\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP with functional readout, single lab, two orthogonal methods (binding + signaling assay)\",\n      \"pmids\": [\"12024021\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"CARD9 mediates Dectin-1-induced ERK activation by linking Ras-GRF1 to H-Ras: Dectin-1 engagement initiates Syk-dependent phosphorylation of Ras-GRF1, and phosphorylated Ras-GRF1 recruits and activates H-Ras through forming a complex with CARD9, leading to downstream ERK activation and antifungal cytokine production.\",\n      \"method\": \"Co-immunoprecipitation, phosphorylation assays, CARD9 KO cells, ERK activation assays, in vivo infection model\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — Co-IP showing complex formation, KO functional phenotype, in vivo validation, multiple orthogonal methods\",\n      \"pmids\": [\"25267792\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Phosphorylation of Ras-GRF1 at Ser916 is a major in vivo phosphorylation site required for full activation of its guanine nucleotide exchange activity by muscarinic receptors; Ser916 is a substrate for protein kinase A both in vivo and in vitro, establishing a link between the cAMP and Ras signaling systems, though PKA phosphorylation alone is not sufficient to activate RasGRF1.\",\n      \"method\": \"Site-directed mutagenesis, in vivo phosphorylation mapping, in vitro kinase assay, GEF activity assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — site-directed mutagenesis with in vitro kinase assay and in vivo phosphorylation, functional GEF activity readout\",\n      \"pmids\": [\"10601308\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Phosphorylation of Ras-GRF1 at Ser916/898 is required for maximal Ras-dependent neurite outgrowth in PC12 cells and is increased by protein kinase A activation in brain slices; a phospho-specific antibody confirmed regulated phosphorylation of endogenous Ras-GRF1 in rat forebrain, including in the dendritic tree of prefrontal cortex neurons.\",\n      \"method\": \"Phospho-specific antibody, confocal immunofluorescence, 32P incorporation in brain slices, mutagenesis, neurite outgrowth assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — mutagenesis with functional assay, phospho-specific antibody validation in endogenous tissue, multiple orthogonal methods\",\n      \"pmids\": [\"12538592\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Ras-GRF1 has separate GEF activities for H-Ras (through its Cdc25 domain) and Rac1 (through its DH domain); coordinated activation of both is required for full morphological effects in neurons. The Rac GEF-containing truncation (GRFdeltaC) binds H-Ras·GTP directly, coupling H-Ras activation to Rac-dependent cell expansion via PI3K/Akt.\",\n      \"method\": \"Truncation mutant expression, pulldown assays from bacterial lysates, co-immunoprecipitation from HEK293 cells, dominant-negative Rac1/RhoA, pharmacological inhibitors (wortmannin), morphological analysis\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — domain dissection with mutagenesis, in vitro pulldown and Co-IP, functional morphological readout with multiple inhibitors\",\n      \"pmids\": [\"16481401\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Filamin A (FLNa) down-regulates Ras-GRF1 protein stability through destabilization and ubiquitylation of Ras-GRF1, thereby suppressing constitutive H-Ras/MAPK-ERK activation and reducing MMP-9 transcription in melanoma cells; ectopic Ras-GRF1 restores ERK activation and MMP-9 elevation, while a catalytically inactive dominant-negative Ras-GRF1 reduces MMP-9 expression.\",\n      \"method\": \"Ubiquitylation assay, MMP-9 promoter-luciferase reporter, dominant-negative Ras-GRF1, ectopic expression, in vitro kinase assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — dominant-negative and overexpression with functional readout, ubiquitylation assay, single lab\",\n      \"pmids\": [\"17389601\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Ras-GRF1 is expressed in pancreatic islets; GRF1-deficient mice exhibit impaired beta-cell proliferation and reduced neogenesis, and isolated islets from GRF1 knockouts fail to activate Akt and Erk downstream of IGF-I treatment, demonstrating that Ras-GRF1 is required for IGF-I signaling in beta cells.\",\n      \"method\": \"Knockout mice, isolated islet IGF-I stimulation, immunoblot for Akt/Erk activation, glucose tolerance tests, histology\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean KO with defined cellular signaling phenotype, multiple orthogonal measurements (signaling, proliferation, metabolic function)\",\n      \"pmids\": [\"12805218\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"Human H-GRF55/RASGRF1 encodes a Ras-specific guanine nucleotide-releasing factor that functions in vitro to promote GDP release from Ras; expression in yeast reverses cdc25.5 and RAS2 Ala-22 mutations, and in CHO cells transactivates a Ras-responsive reporter element.\",\n      \"method\": \"In vitro GEF assay with recombinant GST-fusion protein, yeast complementation, mammalian cell reporter assay\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct in vitro GEF assay, yeast genetic complementation, mammalian functional assay — multiple independent systems\",\n      \"pmids\": [\"7684828\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"The differentially methylated domain (DMD) at the Rasgrf1 locus functions as an enhancer blocker that binds CTCF in a methylation-sensitive manner; CTCF binds the unmethylated maternal allele to silence expression, while repeat-mediated methylation on the paternal allele prevents CTCF binding and allows expression.\",\n      \"method\": \"CTCF binding assays, in vitro enhancer-blocking assay, in vivo imprinting analysis with extra-enhancer transgene, methylation analysis\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct CTCF binding assay, in vitro and in vivo enhancer-blocking, multiple experimental systems\",\n      \"pmids\": [\"16314537\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"A direct repeat sequence immediately 3' of the differentially methylated domain (DMD) at Rasgrf1 is required for establishing paternal allele-specific DNA methylation in the male germ line; loss of the repeat abolishes DMD methylation and imprinted expression, establishing the repeat-DMD binary switch as the imprinting control region.\",\n      \"method\": \"Targeted deletion of repeat sequence in mice, bisulfite methylation analysis, allele-specific expression analysis\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct in vivo genetic deletion with methylation and expression phenotype, multiple analyses\",\n      \"pmids\": [\"11753386\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"piRNA pathway components are required for de novo methylation of the Rasgrf1 DMD in the paternal germ line; piRNAs generated from a separate locus target a retrotransposon sequence within a noncoding RNA spanning the DMD, and the direct repeat acts as a promoter for this RNA, directing sequence-specific methylation.\",\n      \"method\": \"piRNA pathway mutant mice (Mili, Miwi2 knockouts), bisulfite sequencing, RNA analysis\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO of piRNA pathway components with direct methylation phenotype at endogenous locus, multiple pathway mutants\",\n      \"pmids\": [\"21566194\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Ras-GRF1 is required for ERK1/2 activation by glutamate or dopamine D1 receptor agonists in striatal medium spiny neurons of the direct pathway; Ras-GRF1 integrates glutamate and dopamine signals to activate ERK and drive long-term behavioral responses to cocaine including locomotor sensitization and conditioned place preference.\",\n      \"method\": \"Ras-GRF1 KO and overexpressing transgenic mice, striatal primary cultures, organotypic slices, immunoblot/immunofluorescence for pERK, behavioral assays\",\n      \"journal\": \"Biological psychiatry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — KO and gain-of-function with defined signaling and behavioral phenotypes, multiple orthogonal methods\",\n      \"pmids\": [\"19446794\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Dominant-negative forms of Ras-GRF1 delivered by lentiviral vectors into the striatum cause dramatic reversion of L-DOPA-induced dyskinesia in a non-human primate model, demonstrating that Ras-GRF1-dependent Ras-ERK signaling in the striatum is mechanistically required for dyskinesia expression.\",\n      \"method\": \"Ras-GRF1 KO mice, lentiviral dominant-negative Ras-GRF1 in primate model, behavioral scoring (AIMs scale)\",\n      \"journal\": \"PNAS\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO and dominant-negative intervention with quantitative behavioral phenotype, replicated across rodent and primate models\",\n      \"pmids\": [\"21115823\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"The microtubule-destabilizing factor SCLIP binds the Dbl-homology (DH) domain of RasGRF1 (identified by yeast two-hybrid) and selectively inhibits RasGRF1-mediated activation of the Rac/p38 MAPK pathway without affecting the Ras/ERK pathway; SCLIP co-expression counteracts RasGRF1-induced neurite outgrowth in PC12 cells.\",\n      \"method\": \"Yeast two-hybrid, co-immunoprecipitation, Rac/p38 and Ras/ERK activity assays, neurite outgrowth assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — yeast two-hybrid with Co-IP confirmation, functional pathway dissection, single lab\",\n      \"pmids\": [\"17135267\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Gs-coupled serotonin 5-HT7 receptor stimulation induces protein kinase A-dependent phosphorylation of endogenous human Ras-GRF1 at Ser927 (equivalent to mouse Ser916), and deletion of the Ca2+/calmodulin-binding IQ domain (residues 1-225) reduces both basal and serotonin-stimulated ERK1/2 phosphorylation, indicating the IQ domain is required for full Ras-GRF1 activity downstream of Gs-coupled receptors.\",\n      \"method\": \"Phosphorylation assay, deletion mutant expression, ERK1/2 phosphorylation immunoblot, intracellular Ca2+ measurement\",\n      \"journal\": \"The FEBS journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — deletion mutant with functional signaling readout, endogenous phosphorylation confirmed, single lab\",\n      \"pmids\": [\"15853814\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"RasGRF1 directly interacts with the intracellular domain of the activated TrkA receptor tyrosine kinase in a kinase-activity-dependent manner (yeast two-hybrid and in vitro), and RasGRF1 is directly phosphorylated by TrkA; the interaction is highly specific for TrkA over TrkB and TrkC and is independent of the major TrkA phosphotyrosine sites Tyr499 and Tyr794.\",\n      \"method\": \"Yeast two-hybrid, in vitro kinase assay, specificity comparisons with TrkB/TrkC\",\n      \"journal\": \"Journal of molecular neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — yeast two-hybrid with in vitro kinase confirmation, multiple Trk specificity comparisons, single lab\",\n      \"pmids\": [\"10691301\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"The transcription factor Zac1/Plagl1 directly represses Rasgrf1 expression in pancreatic beta cells; doubling Zac1 expression reduces Rasgrf1 levels, impairs stimulus-induced MAPK and PI3K pathway activation, and reduces insulin secretion, and normalizing Rasgrf1 expression reverses this phenotype.\",\n      \"method\": \"Transfection/overexpression in beta cells, rescue by Rasgrf1 normalization, MAPK/PI3K pathway assays, insulin secretion assay, diabetic mouse transplantation model\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — causal rescue experiment with signaling readout, multiple functional assays, single lab\",\n      \"pmids\": [\"22547676\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Disruption of the NR2B-RasGRF1 interaction dramatically impairs dendritic branch formation in ventral spinal cord neurons and hippocampal neurons, establishing that the NR2B-RasGRF1 association is required for NR2B-driven dendritogenesis.\",\n      \"method\": \"NR2B interaction-disrupting mutants, NR2-null neurons with exogenous NR2A or NR2B introduction, dendritic morphology analysis, electrophysiology\",\n      \"journal\": \"Journal of neurophysiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — specific interaction disruption mutants with defined morphological and electrophysiological phenotypes, single lab\",\n      \"pmids\": [\"20107120\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"CARD9 p.Y91H mutation specifically impairs the ability of CARD9 to complex with RASGRF1 (while BCL10/MALT1 association is intact), leading to impaired activation of ERK and NF-κB in monocytes and a defective GM-CSF response, establishing the CARD9/RASGRF1/ERK/GM-CSF axis as critical for antifungal immunity.\",\n      \"method\": \"Immunoprecipitation (CARD9-RASGRF1 complex), signaling assays (pERK, NF-κB) in patient-derived cells, CARD9 mutant analysis\",\n      \"journal\": \"The Journal of allergy and clinical immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP with hypomorphic mutant and functional signaling/cytokine readout in primary patient cells, single lab\",\n      \"pmids\": [\"26521038\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"RasGRF1 is required for activation of the Ras/ERK and AKT pathways downstream of pro-metastatic factors (SDF-1, HGF/SF, IGF-2, insulin) in alveolar rhabdomyosarcoma cells; shRNA knockdown of RasGRF1 abolishes ligand-induced MAPK/AKT phosphorylation and eliminates chemotactic responses, and RasGRF1-depleted cells form significantly smaller tumors in vivo.\",\n      \"method\": \"shRNA knockdown, MAPK/AKT phosphorylation assays, chemotaxis assay, xenograft tumor model\",\n      \"journal\": \"International journal of oncology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — RNAi with defined signaling and in vivo phenotype, single lab\",\n      \"pmids\": [\"22752028\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"The NR2B-NMDAR/RasGRF1/NOX2 pathway promotes superoxide production required for dendritogenesis; disrupting the NR2B-RasGRF1 interaction reduces superoxide levels (measured with DHE) and inhibits dendritic branching in hippocampal neurons, placing RasGRF1 as a required intermediary between NR2B-NMDARs and NOX2-dependent reactive oxygen species generation.\",\n      \"method\": \"Dihydroethidium (DHE) fluorescence for superoxide detection, NR2B-RasGRF1 interaction-disrupting peptide, dendritic branching analysis in primary hippocampal neurons\",\n      \"journal\": \"Journal of cellular physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — specific interaction disruption with functional superoxide and morphological readouts, single lab\",\n      \"pmids\": [\"31245854\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"GRF1 is expressed in newly born hippocampal neurons and promotes late stages of adult neurogenesis (dendritic arborization and survival of 2-3 week-old new neurons) in an age-dependent manner; retroviral shRNA knockdown specifically in new neurons phenocopies the reduced neurogenesis of global GRF1 knockout.\",\n      \"method\": \"Knockout mice, BrdU labeling, retroviral shRNA in new neurons, dendritic morphology analysis\",\n      \"journal\": \"Hippocampus\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — cell-autonomous KD with retrovirus phenocopies global KO, multiple measures of neurogenesis\",\n      \"pmids\": [\"24174283\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"BDNF induces R-Ras activation through RasGRF1 acting as a GEF for R-Ras; RNAi knockdown and overexpression experiments show RasGRF1 is required for BDNF-induced R-Ras activation and axonal growth, and PKA-dependent phosphorylation of RasGRF1 at Ser916/898 is required for full GEF activity in this pathway.\",\n      \"method\": \"RNA interference, overexpression, R-Ras activation assay (pulldown), axonal morphology analysis, phosphorylation assay\",\n      \"journal\": \"Biochemistry and biophysics reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — RNAi and overexpression with R-Ras activity pulldown and functional axonal growth readout, single lab\",\n      \"pmids\": [\"30582008\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"TrkB activation by BDNF uncouples RasGRF1 from NR2B and recruits it to TrkB; NMDA stimulation recruits RasGRF1 to NR2B, but co-stimulation with BDNF shifts RasGRF1 association to TrkB, and TrkB stimulates tyrosine phosphorylation of RasGRF1, promoting ERK activation and neurite outgrowth while reducing NR2B-LTD signaling.\",\n      \"method\": \"Co-immunoprecipitation (competitive association NR2B vs TrkB), neurite outgrowth assay, phosphorylation assay\",\n      \"journal\": \"Journal of molecular neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP showing competitive binding with functional signaling readout, single lab\",\n      \"pmids\": [\"30547417\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"MLL deficiency decreases H3K4me3 at the Rasgrf1 locus, suppressing Rasgrf1 expression; Rasgrf1 is essential for the GTP-bound active state of Kras and activation of Kras downstream pathways; RASGRF1 fusions (TMEM87A-RASGRF1, OCLN-RASGRF1, SLC4A4-RASGRF1, IQGAP1-RASGRF1) increase cellular GTP-RAS levels, induce cellular transformation, and promote in vivo tumorigenesis, with sensitivity to RAF-MEK-ERK pathway inhibition.\",\n      \"method\": \"Genetically engineered mouse models, ChIP-seq (H3K4me3), CRISPR-Cas9 edited cell lines, Ras-GTP pulldown, transformation assays, xenograft models, MEK inhibitor treatment\",\n      \"journal\": \"Cancer research / Clinical cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple independent labs, CRISPR engineering, in vitro and in vivo functional validation, mechanistic chromatin and signaling data\",\n      \"pmids\": [\"36098964\", \"35247929\", \"32312893\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"VLDLR interacts with RasGRF1 (co-immunoprecipitation), and knockdown of RasGRF1 blocks VLDLR-induced increases in dendritic spine number in hippocampal neurons; VLDLR cannot rescue spine deficits caused by loss of CaMKIIα or CaMKIIβ, placing RasGRF1 downstream of VLDLR and requiring CaMKII for the VLDLR-RasGRF1 spinogenesis pathway.\",\n      \"method\": \"Co-immunoprecipitation, shRNA knockdown, dendritic spine morphology analysis in primary hippocampal cultures\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — Co-IP and RNAi epistasis, defined morphological phenotype, single lab\",\n      \"pmids\": [\"25644714\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"The N-terminal PHCCIQ region of RasGRF1 interacts with ribosomal proteins, cytoskeletal proteins, and proteins involved in vesicular trafficking from mouse brain extracts; the PHCCIQ domain exhibits RNA-binding properties, associating with poly(A)-containing RNA and ribosomal protein S6.\",\n      \"method\": \"Affinity purification with chitin-binding domain fusion, mass spectrometry, co-immunoprecipitation, poly(A)-Sepharose binding\",\n      \"journal\": \"Journal of molecular neuroscience\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — large-scale affinity pull-down with limited individual validation, single lab, no functional consequence established\",\n      \"pmids\": [\"18607774\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Matrix stiffness activates RasGRF1, leading to increased Ras-GTP levels and downstream activation of both AKT and ERK pathways; RasGRF1-dependent AKT activation leads to FOXO3a phosphorylation/inactivation and Bim degradation, promoting lung fibroblast survival on stiff substrates; RNAi depletion of FOXO3a or Bim recapitulates the survival phenotype.\",\n      \"method\": \"RNAi knockdown of RasGRF1, pharmacological AKT/ERK inhibitors, Ras-GTP pulldown assay, FOXO3a/Bim western blot, fibroblast survival assay on hydrogels of varying stiffness\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — RNAi with defined signaling and survival phenotype, multiple pathway inhibitors and downstream validation, single lab\",\n      \"pmids\": [\"39793891\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"RASGRF1 is a brain-enriched (but not exclusively neuronal) calcium/calmodulin-dependent guanine nucleotide exchange factor that activates H-Ras and Rac1 through distinct catalytic domains (CDC25/Cdc25 and DH, respectively); it couples NR2B-containing NMDA receptors to the Rac/p38 MAPK pathway promoting LTD, integrates dopamine and glutamate signals in striatal neurons via Ras-ERK to control synaptic plasticity and drug-induced behaviors, is activated by PKA-mediated phosphorylation at Ser916/898, forms a complex with CARD9 to link Dectin-1/Syk to H-Ras/ERK in innate immunity, is required for IGF-I-dependent beta-cell proliferation and survival signaling, and is regulated at the epigenetic level by piRNA-directed DMD methylation (paternal imprinting via CTCF-dependent enhancer blocking) that controls its tissue-specific monoallelic expression.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"RASGRF1 is a calcium/calmodulin-regulated guanine nucleotide exchange factor that couples cell-surface receptors to small-GTPase signaling, acting on H-Ras through its Cdc25 domain and on Rac1 through its DH domain, with coordinated engagement of both activities required for its full morphological effects in neurons [#9, #6]. In the nervous system it is a dedicated effector of NR2B-containing NMDA receptors, binding the NR2B subunit (not NR2A or NR1) to drive NMDAR-dependent ERK activation and to route signaling toward the Rac/p38 MAPK cascade that promotes hippocampal LTD, dendritogenesis, and superoxide production via NOX2 [#0, #1, #19, #22]. Its catalytic output is gated by PKA-dependent phosphorylation at Ser916/898 (human Ser927), a regulatory node engaged downstream of muscarinic, Gs-coupled 5-HT7, and other receptors that is required for maximal GEF activity and Ras-dependent neurite outgrowth [#4, #5, #16]. RASGRF1 integrates dopamine D1 and glutamate signals in striatal medium spiny neurons to activate Ras-ERK, controlling cocaine-induced behavioral plasticity and L-DOPA-induced dyskinesia [#13, #14]. Beyond neurons it links the Dectin-1/Syk/CARD9 module to H-Ras/ERK for antifungal cytokine responses [#3, #20], is required for IGF-I-dependent beta-cell proliferation and survival signaling [#8], and supports Ras/ERK and AKT signaling driving tumorigenesis, including oncogenic RASGRF1 fusions that elevate GTP-RAS and confer RAF-MEK-ERK inhibitor sensitivity [#21, #26]. The locus is subject to paternal imprinting controlled by a CTCF-dependent, methylation-sensitive differentially methylated domain whose paternal methylation is established by a 3' direct repeat and the piRNA pathway [#10, #11, #12].\",\n  \"teleology\": [\n    {\n      \"year\": 1993,\n      \"claim\": \"Established that the human gene encodes a functional Ras-specific guanine nucleotide-releasing factor, defining its core biochemical activity.\",\n      \"evidence\": \"In vitro GEF assay with recombinant protein, yeast complementation of cdc25/RAS2 mutants, and mammalian Ras-responsive reporter\",\n      \"pmids\": [\"7684828\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not address regulation by calcium/calmodulin or receptors\", \"No cellular context or upstream activator identified\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Identified PKA phosphorylation at Ser916 as a regulatory input linking cAMP signaling to RASGRF1 GEF activity, answering how receptor signals tune its catalysis.\",\n      \"evidence\": \"Site-directed mutagenesis, in vivo phosphorylation mapping, in vitro PKA kinase assay, and GEF activity readout downstream of muscarinic receptors\",\n      \"pmids\": [\"10601308\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"PKA phosphorylation alone insufficient for activation; additional inputs unresolved\", \"Structural basis of phospho-activation unknown\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Showed RASGRF1 directly and specifically binds activated TrkA and is a TrkA substrate, providing a receptor tyrosine kinase entry point distinct from GPCRs.\",\n      \"evidence\": \"Yeast two-hybrid and in vitro kinase assay with TrkB/TrkC specificity comparisons\",\n      \"pmids\": [\"10691301\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab, no cellular functional consequence established\", \"Tyr phosphosites on RASGRF1 not mapped\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Defined how RASGRF1 biases output toward p38 by binding the IB2/JIP2 scaffold that assembles the MLK3-MKK3-p38 cassette.\",\n      \"evidence\": \"Co-immunoprecipitation and kinase activation assays in overexpression systems\",\n      \"pmids\": [\"12024021\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab, largely overexpression-based\", \"Endogenous scaffold complex stoichiometry unresolved\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Identified the direct, subunit-specific NR2B–RASGRF1 interaction as the molecular link coupling NR2B-NMDARs to ERK.\",\n      \"evidence\": \"Reciprocal Co-IP in vivo and in vitro plus interaction-disrupting peptides in living neurons with ERK readout\",\n      \"pmids\": [\"14622581\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Binding interface on NR2B not mapped at residue level\", \"How Ca2+ entry triggers complex remodeling unresolved\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Extended PKA regulation to function, showing Ser916/898 phosphorylation is required for Ras-dependent neurite outgrowth and occurs on endogenous brain RASGRF1.\",\n      \"evidence\": \"Phospho-specific antibody, 32P labeling in brain slices, mutagenesis, and neurite outgrowth assays\",\n      \"pmids\": [\"12538592\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Upstream kinase activation in vivo context partial\", \"Quantitative contribution of each site unresolved\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Established a peripheral, non-neuronal role: RASGRF1 is required for IGF-I-driven Akt/Erk activation and beta-cell proliferation.\",\n      \"evidence\": \"Knockout mice, isolated islet IGF-I stimulation immunoblots, glucose tolerance, and histology\",\n      \"pmids\": [\"12805218\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct GEF coupling to the IGF-I receptor not demonstrated\", \"Mechanism of IGF-I-dependent recruitment unknown\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Resolved imprinting control: the DMD acts as a methylation-sensitive CTCF enhancer blocker dictating monoallelic expression.\",\n      \"evidence\": \"CTCF binding assays, in vitro and in vivo enhancer-blocking, and methylation analysis\",\n      \"pmids\": [\"16314537\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Tissue-specific enhancer targets not enumerated\", \"Connection of imprinting to physiological RASGRF1 dosage incomplete\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Showed Gs-coupled 5-HT7 receptors drive PKA phosphorylation of human RASGRF1 (Ser927) and that the Ca2+/calmodulin IQ domain is required for full ERK output.\",\n      \"evidence\": \"Phosphorylation and IQ-deletion mutant analysis with ERK immunoblot and Ca2+ measurement\",\n      \"pmids\": [\"15853814\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"Interplay between Ca2+/CaM and PKA inputs not quantitatively dissected\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Genetically separated RASGRF1 from RASGRF2, assigning RASGRF1 to the NR2B–Rac–p38 LTD axis and RASGRF2 to the NR2A–ERK LTP axis.\",\n      \"evidence\": \"Ras-GRF1 and Ras-GRF2 knockout mice with electrophysiology and NMDAR-subtype pharmacology\",\n      \"pmids\": [\"16467520\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular basis of effector selectivity not fully defined\", \"Developmental timing dependence only partially characterized\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Defined the dual-GEF architecture, showing distinct Cdc25 (H-Ras) and DH (Rac1) domains must act in concert, with H-Ras·GTP binding coupling to Rac via PI3K/Akt.\",\n      \"evidence\": \"Truncation mutants, bacterial-lysate pulldowns, HEK293 Co-IP, dominant-negative Rac1/RhoA, and morphological analysis\",\n      \"pmids\": [\"16481401\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural coupling between domains unresolved\", \"How upstream signals choose H-Ras vs Rac output unclear\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Identified SCLIP as a DH-domain binding partner that selectively dampens the Rac/p38 arm without affecting Ras/ERK, providing an effector-arm-specific brake.\",\n      \"evidence\": \"Yeast two-hybrid, Co-IP, pathway-specific activity assays, and neurite outgrowth in PC12 cells\",\n      \"pmids\": [\"17135267\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"In vivo relevance of SCLIP regulation not tested\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Showed RASGRF1 abundance is controlled post-translationally, with Filamin A driving its ubiquitylation and destabilization to limit H-Ras/ERK and MMP-9 in melanoma.\",\n      \"evidence\": \"Ubiquitylation assay, MMP-9 reporter, dominant-negative and ectopic RASGRF1, and kinase assays\",\n      \"pmids\": [\"17389601\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"E3 ligase mediating ubiquitylation not identified\", \"Single lab\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Placed RASGRF1 as the integrator of dopamine D1 and glutamate signals driving striatal ERK and cocaine-related behaviors.\",\n      \"evidence\": \"Knockout and overexpressing mice, striatal cultures/slices, pERK assays, and behavioral tests\",\n      \"pmids\": [\"19446794\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular coupling of D1/cAMP to RASGRF1 in MSNs only partly defined\", \"Circuit specificity not fully resolved\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Demonstrated therapeutic relevance: striatal dominant-negative RASGRF1 reverses L-DOPA-induced dyskinesia in primates, establishing causal requirement of RASGRF1-Ras-ERK signaling.\",\n      \"evidence\": \"Knockout mice plus lentiviral dominant-negative RASGRF1 in a non-human primate model with AIMs scoring\",\n      \"pmids\": [\"21115823\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream ERK targets mediating dyskinesia not identified\", \"Long-term consequences of striatal RASGRF1 inhibition unknown\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Showed the NR2B–RASGRF1 interaction is required for NR2B-driven dendritic branch formation, linking the complex to neuronal morphogenesis.\",\n      \"evidence\": \"Interaction-disrupting mutants, NR2-null neurons reconstituted with NR2A/NR2B, dendritic morphology, and electrophysiology\",\n      \"pmids\": [\"20107120\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"Downstream effector arm for dendritogenesis not specified here\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Revealed the mechanism establishing paternal DMD methylation: piRNAs targeting a retrotransposon within a DMD-spanning noncoding RNA, with the direct repeat acting as its promoter.\",\n      \"evidence\": \"Mili/Miwi2 knockout mice, bisulfite sequencing, and RNA analysis\",\n      \"pmids\": [\"21566194\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How piRNA-guided complexes recruit de novo methyltransferases at this locus not fully detailed\", \"Generality across tissues not addressed\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Identified the 3' direct repeat as the germ-line element required to establish paternal DMD methylation and imprinted expression.\",\n      \"evidence\": \"Targeted repeat deletion in mice, bisulfite methylation, and allele-specific expression analysis\",\n      \"pmids\": [\"11753386\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which the repeat directs methylation only later resolved\", \"Trans-acting factors not identified at this stage\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Showed transcriptional control of Rasgrf1 by Zac1/Plagl1 in beta cells, linking its dosage to insulin secretion and MAPK/PI3K signaling.\",\n      \"evidence\": \"Overexpression and rescue in beta cells, pathway and insulin secretion assays, and diabetic transplantation model\",\n      \"pmids\": [\"22547676\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct vs indirect repression mechanism partly defined\", \"Single lab\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Established RASGRF1 as required for Ras/ERK and AKT signaling downstream of pro-metastatic ligands and for rhabdomyosarcoma tumor growth.\",\n      \"evidence\": \"shRNA knockdown, MAPK/AKT phosphorylation, chemotaxis, and xenograft tumor assays\",\n      \"pmids\": [\"22752028\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Receptor coupling mechanism to RASGRF1 not defined\", \"Single lab\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Identified the CARD9–RASGRF1 complex linking Dectin-1/Syk to H-Ras/ERK in antifungal innate immunity.\",\n      \"evidence\": \"Co-IP, phosphorylation assays, CARD9 KO cells, ERK readout, and an in vivo infection model\",\n      \"pmids\": [\"25267792\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Syk phosphosites on RASGRF1 not mapped\", \"How phosphorylation enables CARD9/H-Ras recruitment unresolved\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Demonstrated a cell-autonomous role for RASGRF1 in adult hippocampal neurogenesis, promoting dendritic arborization and survival of young neurons.\",\n      \"evidence\": \"Knockout mice, BrdU labeling, and retroviral shRNA in new neurons with morphology analysis\",\n      \"pmids\": [\"24174283\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Upstream activators in new neurons not defined\", \"Age-dependence mechanism unresolved\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Confirmed disease relevance of the CARD9-RASGRF1 axis: a CARD9 Y91H mutation selectively impairs RASGRF1 binding, ERK/NF-κB activation, and GM-CSF responses.\",\n      \"evidence\": \"Co-IP and signaling/cytokine assays in patient-derived monocytes with CARD9 mutant analysis\",\n      \"pmids\": [\"26521038\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"Structural basis of selective RASGRF1 binding loss not defined\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Placed RASGRF1 downstream of VLDLR in CaMKII-dependent dendritic spinogenesis.\",\n      \"evidence\": \"Co-IP, shRNA knockdown, and spine morphology in hippocampal cultures\",\n      \"pmids\": [\"25644714\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab; epistasis-based positioning\", \"Directness of VLDLR-RASGRF1 coupling unclear\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Expanded substrate range, showing RASGRF1 acts as a GEF for R-Ras in BDNF-induced axonal growth, with PKA Ser916/898 phosphorylation required.\",\n      \"evidence\": \"RNAi, overexpression, R-Ras pulldown, axonal morphology, and phosphorylation assays\",\n      \"pmids\": [\"30582008\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"Direct R-Ras GEF kinetics not measured\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Showed receptor competition controls RASGRF1 targeting: TrkB/BDNF recruits RASGRF1 away from NR2B toward TrkB, biasing toward ERK and away from LTD.\",\n      \"evidence\": \"Competitive Co-IP, phosphorylation, and neurite outgrowth assays\",\n      \"pmids\": [\"30547417\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"In vivo significance of the switch not tested\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Defined an effector branch downstream of the NR2B–RASGRF1 complex, showing it drives NOX2-dependent superoxide required for dendritogenesis.\",\n      \"evidence\": \"DHE superoxide detection, interaction-disrupting peptide, and dendritic branching analysis\",\n      \"pmids\": [\"31245854\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"Mechanism coupling RASGRF1 to NOX2 not defined\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Established RASGRF1 as a chromatin-regulated, oncogenic driver: MLL/H3K4me3 controls its expression, it is required for active GTP-Kras, and RASGRF1 fusions transform cells with RAF-MEK-ERK inhibitor sensitivity.\",\n      \"evidence\": \"GEMMs, ChIP-seq, CRISPR-edited cells, Ras-GTP pulldown, transformation and xenograft assays, MEK inhibitor treatment (multiple labs)\",\n      \"pmids\": [\"36098964\", \"35247929\", \"32312893\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether fusion proteins retain calcium/PKA regulation unresolved\", \"Structural basis of fusion-driven GEF activation undefined\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Showed RASGRF1 functions as a mechanosensitive activator, transducing matrix stiffness into Ras-GTP, AKT-FOXO3a-Bim survival signaling in lung fibroblasts.\",\n      \"evidence\": \"RNAi, AKT/ERK inhibitors, Ras-GTP pulldown, FOXO3a/Bim immunoblots, and fibroblast survival assays on variable-stiffness hydrogels\",\n      \"pmids\": [\"39793891\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"Mechanosensing mechanism upstream of RASGRF1 not defined\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How RASGRF1 integrates its Ca2+/calmodulin, PKA, and tyrosine-kinase inputs at the structural level to select between H-Ras, R-Ras, and Rac1 outputs in a given cell type remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structural model of full-length regulated RASGRF1\", \"Quantitative rules governing effector selection unknown\", \"Whether oncogenic fusions bypass normal regulatory inputs untested\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [9, 6, 24]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [9, 6, 26]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [0, 3]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 3]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [6]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [9, 6, 0]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [1, 13, 19]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [3, 20]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [26, 21]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"GRIN2B\", \"CARD9\", \"H-Ras\", \"RAC1\", \"NTRK1\", \"NTRK2\", \"FLNA\", \"VLDLR\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"faith_supported":6,"faith_total":6,"faith_pct":100.0}}